BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $5,537,000 | +61.5% | 64,300 | +44.5% | 0.32% | +32.4% |
Q3 2018 | $3,429,000 | +4.6% | 44,484 | +0.2% | 0.24% | +2.6% |
Q2 2018 | $3,278,000 | +13.5% | 44,400 | 0.0% | 0.24% | +13.0% |
Q1 2018 | $2,888,000 | -17.5% | 44,400 | -18.1% | 0.21% | -16.8% |
Q4 2017 | $3,502,000 | +3.0% | 54,200 | 0.0% | 0.25% | -2.3% |
Q3 2017 | $3,401,000 | -3.1% | 54,200 | -6.6% | 0.26% | +2.4% |
Q2 2017 | $3,511,000 | +16.8% | 58,000 | 0.0% | 0.25% | +23.8% |
Q1 2017 | $3,007,000 | -0.2% | 58,000 | -14.7% | 0.20% | -18.5% |
Q4 2016 | $3,014,000 | -71.3% | 68,000 | -69.2% | 0.25% | -64.7% |
Q3 2016 | $10,505,000 | -10.7% | 220,700 | -15.2% | 0.70% | -3.0% |
Q2 2016 | $11,770,000 | +50.6% | 260,300 | +36.9% | 0.72% | +45.0% |
Q1 2016 | $7,814,000 | -54.5% | 190,200 | -23.3% | 0.50% | -60.7% |
Q2 2013 | $17,181,000 | – | 248,000 | – | 1.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |